These findings suggest that, although plasma EV-EAAT2 levels are significantly increased in all clinical MS forms respect to healthy controls, the highest EV-EAAT2 levels are observed in relapsing RRMS patients. The gene discussed is SLC1A2; the disease is relapsing-remitting multiple sclerosis.